| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows From Operating Activities: | ||||||||||
Net Income (Loss) Attributable to Parent | ||||||||||
-249 | -105 | 181 | -45 | -31 | -179 | -187 | 222 | -9 | 6 | -1 |
Adjustments to reconcile net income (loss) to net cash and cash collateral posted to counterparties provided by (used in) operating activities: | ||||||||||
Accretion (Amortization) of Discounts and Premiums, Investments, Available-for-Sale | ||||||||||
-53 | -32 | -44 | -77 | -109 | -82 | -157 | -123 | -34 | -3 | 0 |
Accretion (Amortization) of Discounts and Premiums, Investments, Trading | ||||||||||
- | - | - | 2 | 0 | 0 | - | - | - | - | - |
Realized (gain) loss on sale of Agency Securities | ||||||||||
9 | -152 | -8 | -18 | -11 | 68 | -593 | 40 | 16 | 0 | - |
Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings | ||||||||||
0 | 12 | 13 | 6 | 0 | 0 | 401 | 0 | 0 | - | - |
Loss on short sale of U.S. Treasury Securities | ||||||||||
- | - | - | - | - | -14 | 15 | 0 | 0 | - | - |
Stock based compensation | ||||||||||
2 | 2 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | - | - |
Business Combination, Bargain Purchase, Gain Recognized, Amount | ||||||||||
- | - | - | 6 | 0 | 0 | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||||
Increase (decrease) in accrued interest receivable | ||||||||||
12 | 0 | 3 | -17 | -6 | -0 | -13 | 36 | 14 | 3 | -0 |
Increase in prepaid and other assets | ||||||||||
1 | 0 | 0 | -3 | 2 | 0 | 0 | 0 | -0 | 0 | -0 |
Change in derivatives, at fair value | ||||||||||
-134 | 58 | 69 | 210 | -155 | -483 | 591 | -63 | -119 | - | - |
Increase (Decrease) in accrued interest payable- repurchase agreements | ||||||||||
21 | 3 | -0 | -1 | 0 | 0 | -3 | 7 | 1 | 0 | 0 |
(Increase) decrease in derivatives, at fair value | ||||||||||
- | - | - | - | - | - | - | - | -97 | -2 | - |
Increase in accounts payable and other accrued expenses | ||||||||||
-0 | 0 | -4 | -4 | -12 | -19 | -0 | 3 | 2 | 0 | -0 |
Net cash and cash collateral posted to counterparties used in operating activities | ||||||||||
-40 | 75 | 110 | -203 | 238 | 315 | 369 | 343 | 118 | 9 | -2 |
Cash Flows From Investing Activities: | ||||||||||
Payments to Acquire Debt Securities, Available-for-sale | ||||||||||
8,937 | 4,816 | 5,813 | 2,201 | 5,145 | 12,505 | 15,029 | 20,493 | 6,677 | 1,096 | 60 |
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | ||||||||||
1,701 | 691 | 775 | 1,337 | 1,910 | 1,806 | 3,135 | 2,629 | -834 | -78 | -0 |
Proceeds from Maturities, Repayments and Calls of Debt Securities, FV-NI, Held-for-investment | ||||||||||
53 | 33 | 145 | 53 | 0 | 0 | - | - | - | - | - |
Proceeds from Sale of Debt Securities, Available-for-sale | ||||||||||
2,894 | 4,496 | 4,012 | 7,195 | 5,614 | 10,334 | 15,611 | 3,853 | 1,245 | 31 | - |
Disbursements on reverse repurchase agreements | ||||||||||
- | - | - | - | - | 18,076 | 11,239 | 0 | 0 | - | - |
Receipts from reverse repurchase agreements | ||||||||||
- | - | - | - | - | 18,076 | 11,239 | 0 | 0 | - | - |
(Decrease) increase in cash collateral posted by counterparties | ||||||||||
-82 | 67 | 25 | 3 | -183 | -432 | 617 | -118 | 142 | 4 | 0 |
Net cash used in the acquisition of JAVELIN | ||||||||||
- | - | - | 48 | 0 | 0 | - | - | - | - | - |
Subordinated loan to BUCKLER | ||||||||||
0 | 0 | 105 | 0 | 0 | - | - | - | - | - | - |
Net cash and cash collateral posted to counterparties provided by (used in) investing activities | ||||||||||
-4,389 | 466 | -959 | 5,483 | 2,196 | -796 | 4,335 | -14,129 | -4,739 | -990 | -60 |
Cash Flows From Financing Activities: | ||||||||||
Issuance of common stock, net of expenses | ||||||||||
321 | 38 | 133 | 0 | 0 | 0 | 438 | 1,498 | 561 | 94 | - |
Proceeds from repurchase agreements | ||||||||||
173,216 | 185,437 | 141,685 | 139,917 | 90,941 | 80,982 | 122,761 | 127,326 | 39,069 | 3,837 | 46 |
Principal repayments on repurchase agreements | ||||||||||
168,899 | 185,956 | 140,947 | 145,258 | 93,252 | 80,252 | 127,975 | 114,297 | 34,705 | 2,911 | - |
Proceeds from short sales of U.S. Treasury Securities | ||||||||||
- | - | - | - | - | 2,005 | 2,783 | 0 | - | - | - |
Purchases of U.S. Treasury Securities | ||||||||||
- | - | - | - | - | 2,020 | 2,768 | 0 | - | - | - |
Common stock dividends paid | ||||||||||
124 | 97 | 89 | 111 | 167 | 215 | 292 | 269 | 87 | 8 | 0 |
Cash received from Trust | ||||||||||
- | - | - | - | - | - | - | - | - | - | 249 |
Common stock repurchased, net | ||||||||||
16 | 0 | 0 | 14 | 144 | 5 | 53 | 0 | 0 | - | 226 |
Net cash and cash collateral posted to counterparties provided by (used in) financing activities | ||||||||||
4,471 | -591 | 780 | -5,482 | -2,638 | 479 | -4,979 | 14,304 | 4,838 | 1,010 | 69 |
Net Increase (decrease) in cash and cash collateral posted to counterparties | ||||||||||
40 | -50 | -68 | -202 | -204 | -1 | -274 | 518 | 217 | 28 | 6 |
Supplemental Disclosure: | ||||||||||
Cash paid during the period for interest | ||||||||||
425 | 252 | 164 | 193 | 218 | 215 | 226 | 85 | 9 | 0 | - |
Non-Cash Investing and Financing Activities: | ||||||||||
Receivable for unsettled sales | ||||||||||
- | - | - | - | - | 260 | 0 | 668 | - | - | - |
Payable for unsettled purchases | ||||||||||
358 | 166 | 0 | 0 | - | 445 | 159 | 0 | - | - | - |
Net unrealized gain (loss) on available for sale Agency Securities | ||||||||||
408 | -188 | -13 | 13 | -163 | 343 | -1,416 | 222 | 69 | -4 | 0 |
Amounts receivable for issuance of common stock | ||||||||||
- | - | - | - | - | 0 | 0 | 0 | - | - | - |
Amounts receivable for issuance of preferred stock | ||||||||||
5 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - |
Amounts payable for common stock repurchased | ||||||||||
0 | 0 | 0 | - | -14 | 12 | 19 | 0 | 0 | - | - |
Increase in capital due to waiver of accrued deferred underwriters fees | ||||||||||
- | - | - | - | - | - | - | - | - | - | 8 |
Interest-Only Securities | ||||||||||
Accretion (Amortization) of Discounts and Premiums, Investments, Trading | ||||||||||
-1 | -4 | -4 | -7 | - | - | - | - | - | - | - |
Debt Securities, Trading, Gain (Loss) | ||||||||||
0 | -1 | -2 | 6 | - | - | - | - | - | - | - |
Payments to Acquire Trading Securities Held-for-investment | ||||||||||
0 | 0 | - | 101 | - | - | - | - | - | - | - |
Proceeds from Maturities, Repayments and Calls of Debt Securities, FV-NI, Held-for-investment | ||||||||||
0 | 0 | - | - | - | - | - | - | - | - | - |
Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment | ||||||||||
18 | 0 | 0 | 66 | - | - | - | - | - | - | - |
US Treasury Securities | ||||||||||
Accretion (Amortization) of Discounts and Premiums, Investments, Trading | ||||||||||
0 | 1 | 0 | 0 | - | - | - | - | - | - | - |
Gain (loss) on securities | ||||||||||
- | - | - | 0 | - | - | - | - | - | - | - |
Debt Securities, Trading, Gain (Loss) | ||||||||||
2 | -6 | 0 | 0 | - | - | - | - | - | - | - |
Payments to Acquire Trading Securities Held-for-investment | ||||||||||
1,685 | 765 | 0 | 0 | - | - | - | - | - | - | - |
Proceeds from Maturities, Repayments and Calls of Debt Securities, FV-NI, Held-for-investment | ||||||||||
0 | 0 | - | - | - | - | - | - | - | - | - |
Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment | ||||||||||
1,786 | 661 | 0 | 0 | - | - | - | - | - | - | - |
Credit Risk and Non-Agency Securities | ||||||||||
Accretion (Amortization) of Discounts and Premiums, Investments, Trading | ||||||||||
2 | 2 | 3 | - | - | - | - | - | - | - | - |
Debt Securities, Trading, Gain (Loss) | ||||||||||
-24 | -27 | 65 | 59 | - | - | - | - | - | - | - |
Payments to Acquire Trading Securities Held-for-investment | ||||||||||
138 | 0 | 8 | 882 | - | - | - | - | - | - | - |
Proceeds from Maturities, Repayments and Calls of Debt Securities, FV-NI, Held-for-investment | ||||||||||
53 | 33 | - | - | - | - | - | - | - | - | - |
Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment | ||||||||||
0 | 97 | 8 | 61 | - | - | - | - | - | - | - |
Series A Preferred Stock | ||||||||||
Redemption of Series A Preferred stock, net of expenses | ||||||||||
54 | 0 | 0 | - | - | - | - | - | - | - | - |
Preferred stock dividends paid | ||||||||||
2 | 4 | 4 | 4 | - | - | - | - | - | - | - |
Series B Preferred Stock | ||||||||||
Issuance of Preferred stock, net of expenses | ||||||||||
44 | 2 | 14 | 0 | - | - | - | - | - | - | - |
Preferred stock dividends paid | ||||||||||
13 | 12 | 11 | 11 | - | - | - | - | - | - | - |